Overcoming Barriers to Cancer Drug Trial Participation for Patients
Explore the challenges of patient enrollment in cancer clinical trials and how insurance reforms can improve accessibility for those in need.
Personalis Boosts Valuation on Medicare Reimbursement and Strong Q3 Revenue
Personalis updates valuation with a raised fair value to $11 per share driven by Medicare reimbursement for its NeXT Personal test and strong Q3 revenue performance. Analysts see durable revenue growth and clinical validation as key drivers.
Georgia Medicare Kickback Sentencing & FDA Updates on Lead Cookware and Primate Testing
Georgia man sentenced for $24M Medicare genetic testing kickback scheme; FDA warns on lead in cookware; new guidance limits primate testing in drug development.